Global Autoimmune Disease Drug Market Research Report 2023
Autoimmune disease is a condition in which the immune system is unable to recognize the body’s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.
According to QYResearch’s new survey, global Autoimmune Disease Drug market is projected to reach US$ 10220 million in 2029, increasing from US$ 6080 million in 2022, with the CAGR of 7.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Autoimmune Disease Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Autoimmune Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Autoimmune Disease Drug market is projected to reach US$ 10220 million in 2029, increasing from US$ 6080 million in 2022, with the CAGR of 7.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Autoimmune Disease Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Autoimmune Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Abbott Laboratories
- Pfizer
- AbbVie
- Eli Lilly
- Bristol-Myers Squibb
- AstraZeneca plc
- GlaxoSmithKline
- Roche
- Biogen
- Amgen
- NSAIDs
- Anti-Inflammatory
- Interferons
- Antihyperglycemics
- Others
- Rheumatoid Arthritis
- Type 1 Diabetes
- Multiple Sclerosis
- Psoriasis
- Lupus
- Inflammatory Bowel Disease
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 NSAIDs
1.2.3 Anti-Inflammatory
1.2.4 Interferons
1.2.5 Antihyperglycemics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Autoimmune Disease Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Rheumatoid Arthritis
1.3.3 Type 1 Diabetes
1.3.4 Multiple Sclerosis
1.3.5 Psoriasis
1.3.6 Lupus
1.3.7 Inflammatory Bowel Disease
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Autoimmune Disease Drug Market Perspective (2018-2029)
2.2 Autoimmune Disease Drug Growth Trends by Region
2.2.1 Global Autoimmune Disease Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Autoimmune Disease Drug Historic Market Size by Region (2018-2023)
2.2.3 Autoimmune Disease Drug Forecasted Market Size by Region (2024-2029)
2.3 Autoimmune Disease Drug Market Dynamics
2.3.1 Autoimmune Disease Drug Industry Trends
2.3.2 Autoimmune Disease Drug Market Drivers
2.3.3 Autoimmune Disease Drug Market Challenges
2.3.4 Autoimmune Disease Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Autoimmune Disease Drug Players by Revenue
3.1.1 Global Top Autoimmune Disease Drug Players by Revenue (2018-2023)
3.1.2 Global Autoimmune Disease Drug Revenue Market Share by Players (2018-2023)
3.2 Global Autoimmune Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Drug Revenue
3.4 Global Autoimmune Disease Drug Market Concentration Ratio
3.4.1 Global Autoimmune Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Drug Revenue in 2022
3.5 Autoimmune Disease Drug Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Drug Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AUTOIMMUNE DISEASE DRUG BREAKDOWN DATA BY TYPE
4.1 Global Autoimmune Disease Drug Historic Market Size by Type (2018-2023)
4.2 Global Autoimmune Disease Drug Forecasted Market Size by Type (2024-2029)
5 AUTOIMMUNE DISEASE DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Autoimmune Disease Drug Historic Market Size by Application (2018-2023)
5.2 Global Autoimmune Disease Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Autoimmune Disease Drug Market Size (2018-2029)
6.2 North America Autoimmune Disease Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Autoimmune Disease Drug Market Size by Country (2018-2023)
6.4 North America Autoimmune Disease Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Autoimmune Disease Drug Market Size (2018-2029)
7.2 Europe Autoimmune Disease Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Autoimmune Disease Drug Market Size by Country (2018-2023)
7.4 Europe Autoimmune Disease Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Autoimmune Disease Drug Market Size (2018-2029)
8.2 Asia-Pacific Autoimmune Disease Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Autoimmune Disease Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Autoimmune Disease Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Autoimmune Disease Drug Market Size (2018-2029)
9.2 Latin America Autoimmune Disease Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Autoimmune Disease Drug Market Size by Country (2018-2023)
9.4 Latin America Autoimmune Disease Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Autoimmune Disease Drug Market Size (2018-2029)
10.2 Middle East & Africa Autoimmune Disease Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Autoimmune Disease Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Autoimmune Disease Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Drug Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Autoimmune Disease Drug Introduction
11.2.4 Pfizer Revenue in Autoimmune Disease Drug Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Autoimmune Disease Drug Introduction
11.3.4 AbbVie Revenue in Autoimmune Disease Drug Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Autoimmune Disease Drug Introduction
11.4.4 Eli Lilly Revenue in Autoimmune Disease Drug Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2018-2023)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Company Detail
11.6.2 AstraZeneca plc Business Overview
11.6.3 AstraZeneca plc Autoimmune Disease Drug Introduction
11.6.4 AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2018-2023)
11.6.5 AstraZeneca plc Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Autoimmune Disease Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Autoimmune Disease Drug Introduction
11.8.4 Roche Revenue in Autoimmune Disease Drug Business (2018-2023)
11.8.5 Roche Recent Development
11.9 Biogen
11.9.1 Biogen Company Detail
11.9.2 Biogen Business Overview
11.9.3 Biogen Autoimmune Disease Drug Introduction
11.9.4 Biogen Revenue in Autoimmune Disease Drug Business (2018-2023)
11.9.5 Biogen Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Autoimmune Disease Drug Introduction
11.10.4 Amgen Revenue in Autoimmune Disease Drug Business (2018-2023)
11.10.5 Amgen Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 NSAIDs
1.2.3 Anti-Inflammatory
1.2.4 Interferons
1.2.5 Antihyperglycemics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Autoimmune Disease Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Rheumatoid Arthritis
1.3.3 Type 1 Diabetes
1.3.4 Multiple Sclerosis
1.3.5 Psoriasis
1.3.6 Lupus
1.3.7 Inflammatory Bowel Disease
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Autoimmune Disease Drug Market Perspective (2018-2029)
2.2 Autoimmune Disease Drug Growth Trends by Region
2.2.1 Global Autoimmune Disease Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Autoimmune Disease Drug Historic Market Size by Region (2018-2023)
2.2.3 Autoimmune Disease Drug Forecasted Market Size by Region (2024-2029)
2.3 Autoimmune Disease Drug Market Dynamics
2.3.1 Autoimmune Disease Drug Industry Trends
2.3.2 Autoimmune Disease Drug Market Drivers
2.3.3 Autoimmune Disease Drug Market Challenges
2.3.4 Autoimmune Disease Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Autoimmune Disease Drug Players by Revenue
3.1.1 Global Top Autoimmune Disease Drug Players by Revenue (2018-2023)
3.1.2 Global Autoimmune Disease Drug Revenue Market Share by Players (2018-2023)
3.2 Global Autoimmune Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Drug Revenue
3.4 Global Autoimmune Disease Drug Market Concentration Ratio
3.4.1 Global Autoimmune Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Drug Revenue in 2022
3.5 Autoimmune Disease Drug Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Drug Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AUTOIMMUNE DISEASE DRUG BREAKDOWN DATA BY TYPE
4.1 Global Autoimmune Disease Drug Historic Market Size by Type (2018-2023)
4.2 Global Autoimmune Disease Drug Forecasted Market Size by Type (2024-2029)
5 AUTOIMMUNE DISEASE DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Autoimmune Disease Drug Historic Market Size by Application (2018-2023)
5.2 Global Autoimmune Disease Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Autoimmune Disease Drug Market Size (2018-2029)
6.2 North America Autoimmune Disease Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Autoimmune Disease Drug Market Size by Country (2018-2023)
6.4 North America Autoimmune Disease Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Autoimmune Disease Drug Market Size (2018-2029)
7.2 Europe Autoimmune Disease Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Autoimmune Disease Drug Market Size by Country (2018-2023)
7.4 Europe Autoimmune Disease Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Autoimmune Disease Drug Market Size (2018-2029)
8.2 Asia-Pacific Autoimmune Disease Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Autoimmune Disease Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Autoimmune Disease Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Autoimmune Disease Drug Market Size (2018-2029)
9.2 Latin America Autoimmune Disease Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Autoimmune Disease Drug Market Size by Country (2018-2023)
9.4 Latin America Autoimmune Disease Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Autoimmune Disease Drug Market Size (2018-2029)
10.2 Middle East & Africa Autoimmune Disease Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Autoimmune Disease Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Autoimmune Disease Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Drug Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Autoimmune Disease Drug Introduction
11.2.4 Pfizer Revenue in Autoimmune Disease Drug Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Autoimmune Disease Drug Introduction
11.3.4 AbbVie Revenue in Autoimmune Disease Drug Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Autoimmune Disease Drug Introduction
11.4.4 Eli Lilly Revenue in Autoimmune Disease Drug Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2018-2023)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Company Detail
11.6.2 AstraZeneca plc Business Overview
11.6.3 AstraZeneca plc Autoimmune Disease Drug Introduction
11.6.4 AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2018-2023)
11.6.5 AstraZeneca plc Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Autoimmune Disease Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Autoimmune Disease Drug Introduction
11.8.4 Roche Revenue in Autoimmune Disease Drug Business (2018-2023)
11.8.5 Roche Recent Development
11.9 Biogen
11.9.1 Biogen Company Detail
11.9.2 Biogen Business Overview
11.9.3 Biogen Autoimmune Disease Drug Introduction
11.9.4 Biogen Revenue in Autoimmune Disease Drug Business (2018-2023)
11.9.5 Biogen Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Autoimmune Disease Drug Introduction
11.10.4 Amgen Revenue in Autoimmune Disease Drug Business (2018-2023)
11.10.5 Amgen Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Autoimmune Disease Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of NSAIDs
Table 3. Key Players of Anti-Inflammatory
Table 4. Key Players of Interferons
Table 5. Key Players of Antihyperglycemics
Table 6. Key Players of Others
Table 7. Global Autoimmune Disease Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Autoimmune Disease Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Autoimmune Disease Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Autoimmune Disease Drug Market Share by Region (2018-2023)
Table 11. Global Autoimmune Disease Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Autoimmune Disease Drug Market Share by Region (2024-2029)
Table 13. Autoimmune Disease Drug Market Trends
Table 14. Autoimmune Disease Drug Market Drivers
Table 15. Autoimmune Disease Drug Market Challenges
Table 16. Autoimmune Disease Drug Market Restraints
Table 17. Global Autoimmune Disease Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Autoimmune Disease Drug Market Share by Players (2018-2023)
Table 19. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2022)
Table 20. Ranking of Global Top Autoimmune Disease Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Autoimmune Disease Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Autoimmune Disease Drug Product Solution and Service
Table 24. Date of Enter into Autoimmune Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Autoimmune Disease Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Autoimmune Disease Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Autoimmune Disease Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Autoimmune Disease Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Autoimmune Disease Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Autoimmune Disease Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Autoimmune Disease Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Autoimmune Disease Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Autoimmune Disease Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Autoimmune Disease Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Abbott Laboratories Company Detail
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Autoimmune Disease Drug Product
Table 52. Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Autoimmune Disease Drug Product
Table 57. Pfizer Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. AbbVie Company Detail
Table 60. AbbVie Business Overview
Table 61. AbbVie Autoimmune Disease Drug Product
Table 62. AbbVie Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Eli Lilly Company Detail
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Autoimmune Disease Drug Product
Table 67. Eli Lilly Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. Bristol-Myers Squibb Company Detail
Table 70. Bristol-Myers Squibb Business Overview
Table 71. Bristol-Myers Squibb Autoimmune Disease Drug Product
Table 72. Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 73. Bristol-Myers Squibb Recent Development
Table 74. AstraZeneca plc Company Detail
Table 75. AstraZeneca plc Business Overview
Table 76. AstraZeneca plc Autoimmune Disease Drug Product
Table 77. AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 78. AstraZeneca plc Recent Development
Table 79. GlaxoSmithKline Company Detail
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Autoimmune Disease Drug Product
Table 82. GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 83. GlaxoSmithKline Recent Development
Table 84. Roche Company Detail
Table 85. Roche Business Overview
Table 86. Roche Autoimmune Disease Drug Product
Table 87. Roche Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 88. Roche Recent Development
Table 89. Biogen Company Detail
Table 90. Biogen Business Overview
Table 91. Biogen Autoimmune Disease Drug Product
Table 92. Biogen Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 93. Biogen Recent Development
Table 94. Amgen Company Detail
Table 95. Amgen Business Overview
Table 96. Amgen Autoimmune Disease Drug Product
Table 97. Amgen Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 98. Amgen Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 1. Global Autoimmune Disease Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of NSAIDs
Table 3. Key Players of Anti-Inflammatory
Table 4. Key Players of Interferons
Table 5. Key Players of Antihyperglycemics
Table 6. Key Players of Others
Table 7. Global Autoimmune Disease Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Autoimmune Disease Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Autoimmune Disease Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Autoimmune Disease Drug Market Share by Region (2018-2023)
Table 11. Global Autoimmune Disease Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Autoimmune Disease Drug Market Share by Region (2024-2029)
Table 13. Autoimmune Disease Drug Market Trends
Table 14. Autoimmune Disease Drug Market Drivers
Table 15. Autoimmune Disease Drug Market Challenges
Table 16. Autoimmune Disease Drug Market Restraints
Table 17. Global Autoimmune Disease Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Autoimmune Disease Drug Market Share by Players (2018-2023)
Table 19. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2022)
Table 20. Ranking of Global Top Autoimmune Disease Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Autoimmune Disease Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Autoimmune Disease Drug Product Solution and Service
Table 24. Date of Enter into Autoimmune Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Autoimmune Disease Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Autoimmune Disease Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Autoimmune Disease Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Autoimmune Disease Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Autoimmune Disease Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Autoimmune Disease Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Autoimmune Disease Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Autoimmune Disease Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Autoimmune Disease Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Autoimmune Disease Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Abbott Laboratories Company Detail
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Autoimmune Disease Drug Product
Table 52. Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Autoimmune Disease Drug Product
Table 57. Pfizer Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. AbbVie Company Detail
Table 60. AbbVie Business Overview
Table 61. AbbVie Autoimmune Disease Drug Product
Table 62. AbbVie Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Eli Lilly Company Detail
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Autoimmune Disease Drug Product
Table 67. Eli Lilly Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. Bristol-Myers Squibb Company Detail
Table 70. Bristol-Myers Squibb Business Overview
Table 71. Bristol-Myers Squibb Autoimmune Disease Drug Product
Table 72. Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 73. Bristol-Myers Squibb Recent Development
Table 74. AstraZeneca plc Company Detail
Table 75. AstraZeneca plc Business Overview
Table 76. AstraZeneca plc Autoimmune Disease Drug Product
Table 77. AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 78. AstraZeneca plc Recent Development
Table 79. GlaxoSmithKline Company Detail
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Autoimmune Disease Drug Product
Table 82. GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 83. GlaxoSmithKline Recent Development
Table 84. Roche Company Detail
Table 85. Roche Business Overview
Table 86. Roche Autoimmune Disease Drug Product
Table 87. Roche Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 88. Roche Recent Development
Table 89. Biogen Company Detail
Table 90. Biogen Business Overview
Table 91. Biogen Autoimmune Disease Drug Product
Table 92. Biogen Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 93. Biogen Recent Development
Table 94. Amgen Company Detail
Table 95. Amgen Business Overview
Table 96. Amgen Autoimmune Disease Drug Product
Table 97. Amgen Revenue in Autoimmune Disease Drug Business (2018-2023) & (US$ Million)
Table 98. Amgen Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Autoimmune Disease Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Autoimmune Disease Drug Market Share by Type: 2022 VS 2029
Figure 3. NSAIDs Features
Figure 4. Anti-Inflammatory Features
Figure 5. Interferons Features
Figure 6. Antihyperglycemics Features
Figure 7. Others Features
Figure 8. Global Autoimmune Disease Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Autoimmune Disease Drug Market Share by Application: 2022 VS 2029
Figure 10. Rheumatoid Arthritis Case Studies
Figure 11. Type 1 Diabetes Case Studies
Figure 12. Multiple Sclerosis Case Studies
Figure 13. Psoriasis Case Studies
Figure 14. Lupus Case Studies
Figure 15. Inflammatory Bowel Disease Case Studies
Figure 16. Others Case Studies
Figure 17. Autoimmune Disease Drug Report Years Considered
Figure 18. Global Autoimmune Disease Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Autoimmune Disease Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Autoimmune Disease Drug Market Share by Region: 2022 VS 2029
Figure 21. Global Autoimmune Disease Drug Market Share by Players in 2022
Figure 22. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Autoimmune Disease Drug Revenue in 2022
Figure 24. North America Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 26. United States Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 30. Germany Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Autoimmune Disease Drug Market Share by Region (2018-2029)
Figure 38. China Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 46. Mexico Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 50. Turkey Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 54. AbbVie Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 57. AstraZeneca plc Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 60. Biogen Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 61. Amgen Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Global Autoimmune Disease Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Autoimmune Disease Drug Market Share by Type: 2022 VS 2029
Figure 3. NSAIDs Features
Figure 4. Anti-Inflammatory Features
Figure 5. Interferons Features
Figure 6. Antihyperglycemics Features
Figure 7. Others Features
Figure 8. Global Autoimmune Disease Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Autoimmune Disease Drug Market Share by Application: 2022 VS 2029
Figure 10. Rheumatoid Arthritis Case Studies
Figure 11. Type 1 Diabetes Case Studies
Figure 12. Multiple Sclerosis Case Studies
Figure 13. Psoriasis Case Studies
Figure 14. Lupus Case Studies
Figure 15. Inflammatory Bowel Disease Case Studies
Figure 16. Others Case Studies
Figure 17. Autoimmune Disease Drug Report Years Considered
Figure 18. Global Autoimmune Disease Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Autoimmune Disease Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Autoimmune Disease Drug Market Share by Region: 2022 VS 2029
Figure 21. Global Autoimmune Disease Drug Market Share by Players in 2022
Figure 22. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Autoimmune Disease Drug Revenue in 2022
Figure 24. North America Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 26. United States Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 30. Germany Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Autoimmune Disease Drug Market Share by Region (2018-2029)
Figure 38. China Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 46. Mexico Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 50. Turkey Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 54. AbbVie Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 57. AstraZeneca plc Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 60. Biogen Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 61. Amgen Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
